Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
CNBC - 2024-04-17T19:45:30.000Z

Eli Lilly's Zepbound showed promise to treat obstructive sleep apnea in two late-stage trials. It's yet another reason to stay invested in the drugmaker.

In related news

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit it to the Food and Drug Administration mid-year.
- Related Articles
- In News
- From CNBC
- 2024-04-17T10:15:01.000Z
What to Know About Weight-Loss Drugs and Sleep Apnea
Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.
- Related Articles
- In News
- From CNET
- 2024-04-18T22:41:00.000Z
Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea. Obstructive sleep apnea is a disorder that causes people to briefly stop breathing while they are sleeping, sometimes several times an hour. This...
- Related Articles
- In News
- From CNN
- 2024-04-17T10:15:23.242Z

In related news

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

What to Know About Weight-Loss Drugs and Sleep Apnea

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says